Form 8-K - Current report:
SEC Accession No. 0001104659-25-101430
Filing Date
2025-10-22
Accepted
2025-10-22 09:29:28
Documents
15
Period of Report
2025-10-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529228d2_8k.htm   iXBRL 8-K 65940
2 EXHIBIT 2.1 tm2529228d2_ex2-1.htm EX-2.1 765688
3 EXHIBIT 2.2 tm2529228d2_ex2-2.htm EX-2.2 32787
4 EXHIBIT 99.1 tm2529228d2_ex99-1.htm EX-99.1 343468
  Complete submission text file 0001104659-25-101430.txt   1643224

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA avdl-20251022.xsd EX-101.SCH 3008
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20251022_lab.xml EX-101.LAB 34239
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20251022_pre.xml EX-101.PRE 22354
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2529228d2_8k_htm.xml XML 3569
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address 10 EARLSFORT TERRACE DUBLIN 2 Ireland D02 T380 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 251408826
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)